ZA912588B - Novel alpha-mannosidase and fucosidase inhibitors - Google Patents

Novel alpha-mannosidase and fucosidase inhibitors

Info

Publication number
ZA912588B
ZA912588B ZA912588A ZA912588A ZA912588B ZA 912588 B ZA912588 B ZA 912588B ZA 912588 A ZA912588 A ZA 912588A ZA 912588 A ZA912588 A ZA 912588A ZA 912588 B ZA912588 B ZA 912588B
Authority
ZA
South Africa
Prior art keywords
alpha
mannosidase
novel alpha
fucosidase inhibitors
fucosidase
Prior art date
Application number
ZA912588A
Other languages
English (en)
Inventor
Robert A Farr
A Farr Robert
Norton P Peet
P Peet Norton
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA912588B publication Critical patent/ZA912588B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA912588A 1990-04-12 1991-04-08 Novel alpha-mannosidase and fucosidase inhibitors ZA912588B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50887590A 1990-04-12 1990-04-12

Publications (1)

Publication Number Publication Date
ZA912588B true ZA912588B (en) 1992-01-29

Family

ID=24024437

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912588A ZA912588B (en) 1990-04-12 1991-04-08 Novel alpha-mannosidase and fucosidase inhibitors

Country Status (19)

Country Link
EP (1) EP0451834B1 (xx)
JP (1) JP2955057B2 (xx)
KR (1) KR100197382B1 (xx)
CN (1) CN1033638C (xx)
AT (1) ATE140692T1 (xx)
AU (1) AU646855B2 (xx)
CA (1) CA2040058C (xx)
DE (1) DE69121000T2 (xx)
DK (1) DK0451834T3 (xx)
ES (1) ES2092520T3 (xx)
FI (1) FI109200B (xx)
GR (1) GR3020934T3 (xx)
HU (1) HU213396B (xx)
IE (1) IE75195B1 (xx)
IL (1) IL97814A (xx)
NO (1) NO175856C (xx)
NZ (1) NZ237734A (xx)
PT (1) PT97339B (xx)
ZA (1) ZA912588B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
JP2001501213A (ja) * 1996-10-01 2001-01-30 グリコデザイン・インコーポレーテツド スワインソニンの新規な３，５，および／または６置換された同族体、それらの製造方法および治療剤としてのそれらの使用
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
WO1999021858A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts
JP6170675B2 (ja) * 2010-01-28 2017-07-26 ラプトール ファーマシューティカルズ インコーポレイテッド 受容体関連タンパク質（ｒａｐ）ペプチド−フコシダーゼ阻害薬複合体による肝障害処置のための方法
CN101870992A (zh) * 2010-06-21 2010-10-27 天津科技大学 利用基因工程菌耦合发酵合成gdp-岩藻糖的方法
CN102286608B (zh) * 2011-06-08 2014-06-25 郑州安图生物工程股份有限公司 衣原体诊断方法和试剂盒

Also Published As

Publication number Publication date
HU911196D0 (en) 1991-10-28
NO911419D0 (no) 1991-04-11
DE69121000D1 (de) 1996-08-29
KR100197382B1 (ko) 1999-06-15
DK0451834T3 (da) 1996-08-26
KR910018341A (ko) 1991-11-30
EP0451834A2 (en) 1991-10-16
PT97339A (pt) 1992-01-31
IL97814A (en) 1995-08-31
FI911751A0 (fi) 1991-04-11
HUT60994A (en) 1992-11-30
FI109200B (fi) 2002-06-14
NO175856C (no) 1994-12-21
AU7416491A (en) 1991-10-17
CA2040058C (en) 2001-10-23
FI911751A (fi) 1991-10-13
IL97814A0 (en) 1992-06-21
ATE140692T1 (de) 1996-08-15
DE69121000T2 (de) 1996-12-19
CN1055732A (zh) 1991-10-30
GR3020934T3 (en) 1996-12-31
IE75195B1 (en) 1997-08-27
EP0451834B1 (en) 1996-07-24
AU646855B2 (en) 1994-03-10
CN1033638C (zh) 1996-12-25
NO911419L (no) 1991-10-14
CA2040058A1 (en) 1991-10-13
EP0451834A3 (en) 1993-10-20
IE911229A1 (en) 1991-10-23
NO175856B (xx) 1994-09-12
NZ237734A (en) 1993-05-26
ES2092520T3 (es) 1996-12-01
HU213396B (en) 1997-06-30
JPH04234834A (ja) 1992-08-24
JP2955057B2 (ja) 1999-10-04
PT97339B (pt) 1998-08-31

Similar Documents

Publication Publication Date Title
ZA953288B (en) Substituted pyridylpyrazoles
ES8502097A1 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
IL97814A0 (en) Novel alpha-mannosidase and fucosidase inhibitors
IT1184730B (it) Procedimento per produrre difenilammine oppure n,n'-difenil-fenilendiammine
FI880213A (fi) System och foerfarande foer att foelja med vaottemperaturen i en roekgasstroem.
EP0406211A3 (en) Fucosidase inhibitors
GR81856B (xx)
IT8721882A0 (it) Apparecchiature per lo scambio di utensili.
FI851142A0 (fi) Superledare med foerbaettrade icke-resis- tiva egenskaper.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
EP0641327A4 (en) NOVEL ALPHA-MANNOSIDASE INHIBITORS.
ITMI910319A0 (it) Processo di dealogenazione di 1,3-diossolani
IT8848548A0 (it) Procedimento per il post-trattamento di substrati tinti, stampati o foulardati
DK0417840T3 (da) Antivirale tetrahydroimidazo(1,4)benzodiazepiner
ITMI912560A0 (it) Processo per la preparazioned di 2-ammino-5,6 dimetossi-tetralina
IT8120307A0 (it) Disposizione per il trattamento termico di pezzi d'opera.
IT8619017A0 (it) Apparecchio per l'incisione di registrazioni.
RO91315A2 (ro) Dispozitiv de blocare a sertarelor meselor centralelor telefonice
IT8718104A0 (it) Apparecchio per la foratura di lamiera.
IT1228963B (it) Tavolo ad elevata flessibilita' di composizione.
IT9021936A0 (it) Nuovo modo di apertura scatole per legumi od altro.
IE890033L (en) TETRAHYDROBENZENE(5,6) ISOINDOLO (2,1-b) ISOQUINOLIN-¹8, 13-DIONE DERIVATIVES
UA11675A1 (uk) 1-БЕtА-ОКСИЕТИЛАМІHО-3-КЕТО-5,5-ДИМЕТИЛЦИКЛОГЕКСЕH -1, ЯКИЙ МАЄ АHАЛЬГЕТИЧHУ АКТИВHІСТЬ
AR241135A2 (es) "derivados de n-triazinil-n-sulfamoilurea herbicidamente activos y formulacion herbicida que los contiene".
ITTO920153A1 (it) Apparecchiatura per il trattamento laser di pezzi.